"It helps us back out of the mind set that said something that doesn't work as a single agent isn't going to be a good drug, " said Dr. Winer.

WSJ: Breast-Cancer Drugs Raise Hopes

The FDA also gave Byetta an "approvable letter" for its use as a single-agent therapy.

FORBES: Magazine Article